Abstract
Brief Reports1 January 1987Methimazole, Carbimazole, and Congenital Skin DefectsCORNELIS P. VAN DIJKE, M.D., Ph.D., ROB J. HEYDENDAEL, M.D., MARTIN J. DE KLEINE, M.D.CORNELIS P. VAN DIJKE, M.D., Ph.D.Search for more papers by this author, ROB J. HEYDENDAEL, M.D.Search for more papers by this author, MARTIN J. DE KLEINE, M.D.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-106-1-60 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptHyperthyroidism during pregnancy generally is treated with antithyroid drugs. In their reviews of the literature, Burrow (1) and Cooper (2) have advised against the use of methimazole (thiamazole) in pregnant women with hyperthyroidism because two studies reported an association of the drug with congenital skin defects (aplasia cutis). In 1972, Milham and Elledge (3) briefly described the cases of 12 patients with congenital scalp defects and noted that in three cases, one of which included a pair of fraternal twins, the mother had taken methimazole during pregnancy. In 1975, Mujtaba and Burrow (4) reported data from their study on the...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
